Birgit C Schultes insider trades

Open-market stock purchases and sales by Birgit C Schultes, EVP, Chief Scientific Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2025.

Recent trades

DateStockTradeValue
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jan 5, 2026NTLA Intellia Therapeutics, IncSold$78.4K

Companies traded

  • NTLA Intellia Therapeutics, Inc: 2 sales, last Mar 1, 2026

Get free alerts when Birgit C Schultes files a new trade →